Our immunofluorescence, flow cytometry, and transcriptional data suggest that PD1+ TCF1+ CD8 T cells can act as tumor-reactive stem-like precursors to the TD1 and TD2 effector populations in BrM. Here, CD8A is linked to neoplasm.